Your browser doesn't support javascript.
loading
Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer.
Cai, Chao; Chen, Jin-Yan; Han, Zhao-Dong; He, Hui-Chan; Chen, Jia-Hong; Chen, Yan-Ru; Yang, Sheng-Bang; Wu, Yong-Ding; Zeng, Yan-Ru; Zou, Jun; Liang, Yu-Xiang; Dai, Qi-Shan; Jiang, Fu-Neng; Zhong, Wei-De.
Afiliación
  • Cai C; Guangdong Provincial Institute of Nephrology, Southern Medical University Guangzhou 510515, China ; Urology Key Laboratory of Guangdong Province, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University Guangzhou 510230, China.
  • Chen JY; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • Han ZD; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • He HC; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • Chen JH; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • Chen YR; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • Yang SB; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • Wu YD; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • Zeng YR; Guangdong Provincial Institute of Nephrology, Southern Medical University Guangzhou 510515, China.
  • Zou J; Guangdong Provincial Institute of Nephrology, Southern Medical University Guangzhou 510515, China.
  • Liang YX; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • Dai QS; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • Jiang FN; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China.
  • Zhong WD; Guangdong Provincial Institute of Nephrology, Southern Medical University Guangzhou 510515, China ; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University Guangzhou 510180, China ; Urology Key La
Int J Clin Exp Med ; 8(3): 4186-94, 2015.
Article en En | MEDLINE | ID: mdl-26064329
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Clin Exp Med Año: 2015 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Clin Exp Med Año: 2015 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos